Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
Arbeitsgemeinschaft medikamentoese Tumortherapie
UNC Lineberger Comprehensive Cancer Center